EMEA-001238-PIP03-21
Key facts
| Active substance |
Vatiquinone
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0543/2021
|
| PIP number |
EMEA-001238-PIP03-21
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of Friedreich's ataxia
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
PTC Therapeutics International Limited
Tel. +353 19068700 |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|